N3510
氯硝柳胺
别名:
2′,5-二氯-4′-硝基水杨酸酰替苯胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C13H8Cl2N2O4
化学文摘社编号:
分子量:
327.12
UNSPSC Code:
51102829
NACRES:
NA.85
PubChem Substance ID:
EC Number:
200-056-8
Beilstein/REAXYS Number:
2820605
MDL number:
InChI key
RJMUSRYZPJIFPJ-UHFFFAOYSA-N
InChI
1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)
SMILES string
Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+]([O-])=O
form
powder
antibiotic activity spectrum
parasites
mode of action
enzyme | inhibits
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
氯硝柳胺是驱虫药系列中的特尼酰胺。它能帮助感染人有效对抗绦虫。氯硝柳胺用于研究Wnt / Frizzled-1信号传导途径。它用于抑制NF-κB转录和DNA结合，并提高ROS水平，诱导急性髓性白血病（AML）细胞凋亡。
Biochem/physiol Actions
氯硝柳胺解偶联绦虫氧化磷酸化，抑制寄生蠕虫线粒体氧化磷酸化。它阻断肿瘤坏死因子诱导的 IκBα 磷酸化、p65 的转位和 AML 细胞中 NF-κβ 调节基因的表达。
Other Notes
50g及250g
将容器密闭保存在干燥和通风良好的地方。在干燥处保存。
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
法规信息
农药列管产品
此项目有
Yanli Jin et al.
Cancer research, 70(6), 2516-2527 (2010-03-11)
NF-kappaB may be a potential therapeutic target for acute myelogenous leukemia (AML) because NF-kappaB activation is found in primitive human AML blast cells. In this report, we initially discovered that the potent antineoplastic effect of niclosamide, a Food and Drug
Mechanism of action of reagents that uncouple oxidative phosphorylation.
E C Weinbach et al.
Nature, 221(5185), 1016-1018 (1969-03-15)
Jing-Xuan Pan et al.
Chinese journal of cancer, 31(4), 178-184 (2012-01-13)
Niclosamide, an oral antihelminthic drug, has been used to treat tapeworm infection for about 50 years. Niclosamide is also used as a molluscicide for water treatment in schistosomiasis control programs. Recently, several groups have independently discovered that niclosamide is also
Andreas Jurgeit et al.
PLoS pathogens, 8(10), e1002976-e1002976 (2012-11-08)
Viruses use a limited set of host pathways for infection. These pathways represent bona fide antiviral targets with low likelihood of viral resistance. We identified the salicylanilide niclosamide as a broad range antiviral agent targeting acidified endosomes. Niclosamide is approved
Jones Gyamfi et al.
Scientific reports, 9(1), 11336-11336 (2019-08-07)
The microenvironment of breast cancer comprises predominantly of adipocytes. Adipocytes drive cancer progression through the secretion adipocytokines. Adipocytes induce epithelial mesenchymal transition of breast cancer cells through paracrine IL-6/Stat3 signalling. Treatment approaches that can target adipocytes in the microenvironment and
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持